Short Interest in Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Increases By 65.5%

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) saw a significant growth in short interest in November. As of November 15th, there was short interest totalling 38,900 shares, a growth of 65.5% from the October 31st total of 23,500 shares. Approximately 2.3% of the shares of the stock are short sold. Based on an average trading volume of 36,700 shares, the short-interest ratio is presently 1.1 days.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Creative Medical Technology stock. Aaron Wealth Advisors LLC increased its stake in Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) by 19.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,570 shares of the company’s stock after acquiring an additional 3,170 shares during the period. Aaron Wealth Advisors LLC owned about 1.45% of Creative Medical Technology worth $75,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 1.42% of the company’s stock.

Creative Medical Technology Stock Up 0.6 %

NASDAQ:CELZ traded up $0.02 during midday trading on Friday, hitting $2.67. The company had a trading volume of 4,004 shares, compared to its average volume of 46,786. Creative Medical Technology has a 52-week low of $2.41 and a 52-week high of $10.28. The stock’s fifty day moving average price is $3.32 and its 200-day moving average price is $3.56.

About Creative Medical Technology

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.